Citrullinylarginine dipeptide analogs and their...

Drug – bio-affecting and body treating compositions – Extract or material containing or obtained from an alga as...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S059000

Reexamination Certificate

active

10801592

ABSTRACT:
The present invention relates to an algal adduct of the citrullinylarginine natural dipeptide as well as to its dermatological use and the use of chemical analogs issued from the same dipeptide displaying no toxic potential, as skin and phanera care and treatment agents, the said analogs having the following general formula (I):in which:R1represents an acyl or acycloxy radical,R2represents a hydroxyl, amine, alkylamine or alcoxy radical,R3represents a hydrogen atom or a hydroxyl radical.

REFERENCES:
patent: 5508033 (1996-04-01), Briand
patent: 6716436 (2004-04-01), Seguin
patent: 1060739 (2000-12-01), None
patent: 1006139 (1999-02-01), None
Ito et al., “Amino Acid Composition of the Ethanolic Extractives From 31 Species of Marine Red Algae,” 16J. Fisheries and Animal Husbandry77-90 (1977)(Abstract).
Laycock et al., “The Occurrence and Seasonal Variation of Gigartinine and L-Citrullinyl-L- Arginine in Chondrus-Crispus,” 55Canadian J. of Biochem. 27-30 (1977)(Abstract).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Citrullinylarginine dipeptide analogs and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Citrullinylarginine dipeptide analogs and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Citrullinylarginine dipeptide analogs and their... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3734217

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.